Today I have this piece by reporter Anton Antonov. Russian doctors and medical researchers are working around the clock to come up with a vaccine for the Covid-19 virus. And, the great thing about it is that they are being completely open and transparent about their approach and methodology. Unlike Westie researchers, who are being secretive and sly. (For obvious reasons: somebody stands to make BILLIONS!)
This according to a man named Alexander Ginzburg, who is the Director of the National Research Center of Epidemiology and Microbiology, named after N.F. Gamaleya. This Institute is located in Moscow, on Gamaleya Street. This Gamaleya, by the way, refers to a man named Nikolai Fyodorovich Gamaleya (1859-1949), an honored Russian/Soviet epidemiologist and bacteriologist who pioneered many vaccines. Both the street and the Institute are named after this outstanding scientist.
Anyhow, Ginzburg complains that the specialists abroad are not being as open and transparent as their Russian colleagues. I mean, everybody is trying to achieve the same thing: a functional vaccine against the coronavirus, right? “Our colleagues from other countries are not fully sharing the technological decisions that they are making. In fact, the scientific community does not even fully understand their approach.”
WE INTERRUPT THIS STORY FOR BREAKING NEWS!
Before proceeding with Ginzburg’s remarks on the Russian methodology, I have this breaking news piece about the first human test subjects for the Russian vaccine. This first (Russian) human trial took place at Sechenovsky University on 18 June, involving 18 volunteers. A second group of 20 volunteers has just started the second set of trials (yesterday, June 23).
The story does not clarify if all 18 test subjects were given the experimental Coronavirus vaccine, or some given a placebo. (I am guessing the former.) They received their injections on June 18. After a few hours, some of the subjects reported a mild mild fever and a headache. But after a day or so, they started feeling better, according Elena Smolyarchuk, who heads the Clinical Research Section. The volunteers are all living in isolation at the clinic, one or two to a room, constantly monitored by doctors and researchers, and also provided with psychological support, if needed. At the same time, the volunteers are being worked by Physical Therapists, and are expected to work out in the gym, so as not to get hypertrophic or put on weight during their isolation.
Returning to Our Regularly Scheduled Programming
Back to the Ginzburg story: Now that we know the experimental vaccine did not kill the volunteers, we can delve more into its structure. Ginzburg: “The approach that we are using is based on the creation of adeno-virus containers as the delivery system of the needed gene. In this case, it’s the gene which codes the protein for the well-known corona that gives the coronavirus its name.” Ginzburg estimates that the vaccine will provide immunity that lasts for at least two years, or possibly even longer. The vaccine will require two separate shots [a first one, and a booster].
Russian public health officials intend to vaccinate the entire Russian population. They will need a minimum of 70 million doses. “This is an unprecedented task.” The Russian government is already taking measures to get the process in motion that will support mass production of the vaccine. Vaccinations might start as early as the fall.
Ginzburg adds that the test systems worked out by the Gamaleya Institute, will permit accurate monitoring of the vaccine’s effectiveness on each person. They will be taking plasma from each patient and studying it. The time is getting close, when the vaccine is ready to be registered, and the mass inoculations about to begin. Who wants to go first?